ERS11 Physiology Of Calcium And Phosphate Metabolism Flashcards
Calcium in our body
- Physiological forms
- **Bones 99%
- **Circulation 1%
—> Free ionised form (50%) - diffusible through capillary —> ***ONLY physiological active form (tightly regulated)
—> Protein-bound form (40%) (e.g. Albumin) - non-diffusible —> sensitive to pH level —> acidosis ↓ protein binding
—> Complexed with anion (10%) - diffusible (e.g. PO4, HCO3, citrate) —> inactive - Range
- tightly regulated within narrow range
- vary with sex, age (higher in younger), physiological status - Absorption and excretion
- adequate intake: Adolescents 1.3g/day, Adult 1g/day
- diet: 10% absorbed, 90% excreted
- inefficient absorption without Vit D: Ca absorption via ***paracellular pathway
- kidney: 99% calcium reabsorbed
- healthy adult: bone formation = bone resorption - Functions
- build and maintain strong bones + teeth
- muscle contraction
- blood coagulation
- neural transmission
- IP3-Ca signalling pathway
Regulation of Ca / PO4 - designed to maintain constant level of ***Ca (唔係PO4!!!) - via 3 hormones: —> Calcitonin —> PTH —> Active Vit D
Phosphate in our body
- Physiological forms
- **85% bone as Hydroxyapatite (Ca, PO4, OH) / CaPO4
—> **Hydroxyapatite: stable crystal —> require extended time to digest / form —> long term regulation of serum Ca
—> ***CaPO4: more simple non-crystalline form, rapid digestion —> used for buffering short term changes in serum Ca, PO4
- Extra-skeletal tissues (14%): phospholipids, phosphoproteins, nucleic acids
- Circulation (1%)
—> Free ionised form (60%) - H2PO4, HPO4
—> Protein-bound form (10%)
—> Complexed with cation (30%) - Range
- allow wider range
- vary with age (higher in infant) - Absorption and excretion
- nearly all ingested is absorbed
- >90% plasma phosphate freely filtered at glomerulus, >80% actively reabsorbed
—> via **proximal tubule via Na-PO4 symporter
—> subject to “transport maximum” but can be regulated by hormone
—> **control how many reabsorbed = control how many excreted (∵ filtration rate is constant) - Functions
- build and maintain strong bones + teeth
- growth, maintainance, repair of cells / tissues (protein, DNA, RNA)
- energy metabolism (ATP synthesis)
- maintain pH balance (chemical buffer to neutralise acids)
Regulation of Ca / PO4- - designed to maintain constant level of ***Ca - via 3 hormones: —> Calcitonin —> PTH —> Active Vit D / Calcitriol
Parathyroid gland
- small glands (20-40mg)
- posterior of thyroid gland
- usually 4
- flattened, oval
- tan colour (fat + vasculature) —> easily confused with surrounding fat when performing surgery
- blood supply: Inferior thyroid artery
Cells (arranged in compact mass)
- Chief cells
- small
- numerous, dense
- produce PTH - Oxyphil cells
- large
- scattered
- unknown function
PTH: synthesis and secretion
- 84 a.a.
- produced in Chief cells
- ***stored in secretory vesicles
- ***released in response to low plasma (Free, Ionised) Ca
- high plasma Ca —> suppress PTH secretion
- opposite to Calcitonin
- Ca level detected by ultrasensitive ***CaSR (GPCR: Gαq) on Chief cells
Low Ca —> CaSR more relaxed, less activation —> removes inhibitory signal —> ***↓ PTH degradation —> ↑ PTH release
High Ca —> Activation of CaSR —> Gαq activation —> Phospholipase C activation —> Phospholipase A2 activation —> Arachidonic acid cascade —> ***PTH degradation —> ↓ PTH release
High PO4
—> ↓ Phospholipase A2 activity
—> removes inhibitory signal (↓ PTH degradation)
—> ↑ PTH release
—> ∴ chronic failure / renal disease patients have ↑ PTH
Vit D
—> ↓ stability of PTH mRNA
—> ↓ PTH release
簡單而言:
Low Ca, High PO4: ↑ PTH
High Ca, Calcitriol: ↓ PTH
Physiological effects of PTH
Bind to PTH receptor (GPCR) in Bone + Kidney
—> activation of Gαq + Gαs (***depend on PTH conc)
—> activation of PLC + Adenyl cyclase
—> IP3-Ca release + ↑ cAMP
Bone (PTH receptor on ***Osteoblast):
1. High [PTH]
—> activate Gαs
—> ↑ cAMP/PKA pathway
—> RANKL production + inhibition of Osteoprotegerin expression (inactivate RANKL)
—> RANKL allowed to bind to RANK on Osteoclast precursors
—> Osteoclastogenesis (proliferation + maturation)
—> Osteoclasts resorb bone by pumping out HCl
—> Dissolve bone mineral
—> ↑ serum Ca
- Low [PTH]
—> activates Gαq
—> PKC activation + IP3-Ca pathway
—> MAPK activation + intracellular Ca release
—> Osteoblast proliferation (accompany (High [Calcitonin]))
—> helping bone formation
—> ↓ serum Ca
Kidney (PTH receptor on Proximal + Distal tubule):
Proximal tubule:
1. ↑ expression of enzymes (1α-Hydroxylase) (from CYP27B1 gene)
—> ***Calcitriol formation (1,25-dihydroxycholecalciferol from 25 hydroxycholecalciferol)
- Stimulates both PLC/PKC + cAMP/PKA pathway
—> PKC: NPT2a mRNA degradation + PKA: NHERF-1 phosphorylation (dissociate from NPT2a —> NPT2a internalisation)
—> NPT2a mRNA + protein degradation
—> ↓ expression of Na/PO4 cotransporter (NPT2a)
—> ↓ renal absorption of PO4
—> ↑ renal excretion of PO4 (vs Calcitriol: ↑ intestinal PO4 absorption)
—> further liberate additional ionised Ca (∵ PO4 bind to Ca)
Distal tubule:
3. Stimulate cAMP/PKA pathway
—> ↑ expression of Ca transport protein: TRPV5 (apical) + NCX1 (basolateral, pump 2 Ca out / 3 Na in)
—> ↑ Ca reabsorption
(Ca reabsorption in distal tubule: regulated by both PTH + Calcitriol —> reinforcement effect)
Physiological effects of Calcitriol
Calcitriol bind to Vit D receptors (steroid receptors acting as transcription factor)
- Intestinal cells
- ↑ expression of apical membrane Ca channel TRPV6
- ↑ expression of intracellular Ca binding protein Calbindin-D9k (trafficking of Ca)
- ↑ expression of basolateral Ca-ATPase (PMCA1b)
—> Allow ***transcellular absorption of Ca
—> ↑ Intestinal Ca absorption
- ↑ expression of Na/PO4 cotransporter (NPT2b) on intestinal brush border membrane
—> ↑ Intestinal PO4 absorption
- Osteoblasts (Negative Ca balance)
- ↑ RANKL expression
—> ↑ Osteoclast formation + action
—> ↑ serum Ca
- ↑ expression of 2 potent mineralisation inhibitors (in extracellular region)
—> Pyrophosphate (PPi) + Osteopontin (OPN) (Glycosylated phosphoprotein)
—> Pyrophosphate / Osteopontin bind Ca
—> Stop PO4 to crystallise with Ca to form Hydroxyapatite
—> Inhibit bone matrix mineralisation
- Distal tubules
- ↑ expression of basolateral Ca-ATPase (PMCA1b)
- ↑ expression of intracellular Ca binding protein Calbindin-D28k
—> ↑ Ca reabsorption
(Ca reabsorption in distal tubule: regulated by both PTH + Calcitriol —> reinforcement effect)
Normal / Negative Ca balance, In vitro / In vivo Vit D
Normal / Positive Ca balance (Normal Ca level —> Normal Calcitriol level):
- Act on intestinal cells —> ↑ serum Ca
- inhibit PTH —> ↑ bone mineral density
Negative Ca balance (Low Ca level —> ↑↑ Calcitriol):
- Osteoblast (i.e. Osteoclastic) effect become dominant —> Bone resorption
Exogenous / In vitro Vit D (e.g. Drugs):
- ↑ bone mineral density under ***normal / positive Ca balance
Endogenous / In vivo Vit D:
- stimulate osteoclastic bone resorption
***Summary of PTH and Calcitriol
Intestine
PTH: N/A
Calcitriol:
- ↑ Ca absorption (via ↑ TRPV6, PMCA1b, Calbindin-D9k)
- ↑ Pi absorption (via ↑ NPT2b)
Kidney
PTH:
- ↑ Ca reabsorption (via ↑ TRPV5, NCX in distal tubules)
- ↓ Pi reabsorption (via ↓ NPT2a in proximal tubules)
- Stimulate Calcitriol production (via 1α-hydroxylase)
Calcitriol:
- ↑ Ca reabsorption (via ↑ PMCA1b, Calbindin-D28k in distal tubules)
Bone:
PTH:
- ↑ Ca + Pi resorption by stimulating osteoclastogenesis (via ↑ RANKL, ↓ Osteoprotegerin)
Calcitriol:
Negative Ca balance
- ↑ Ca + Pi resorption by stimulating osteoclastogenesis (via ↑ RANKL)
- Inhibit bone matrix mineralisation (via ↑ Pyrophosphate, Osteopontin)
- **Normal / Positive Ca balance
- ↑ bone mass by reducing osteoclastogenesis (via ↓ RANKL, ↑ Osteoprotegerin)
- ↓ PTH synthesis and secretion (via retinoid X receptor RXR, Vit D receptor form heterodimer with RXR —> bind to Vit D response element —> block PTH transcription)
Net effect:
PTH: ↑ Ca, ***↓ Pi
Calcitriol: ↑ Ca, ↑ Pi
Disorders related to PTH
- Hyperparathyroidism
- ↑↑ PTH
Primary hyperparathyroidism (自動放多D PTH)
- gland disorder
- tumour in one of parathyroid gland (e.g. Parathyroid adenoma)
—> 結果: ***Hypercalcaemia (↑↑ PTH —> bone demineralisation, ↑ intestinal Ca absorption (via ↑ Calcitriol), ↓ renal Ca excretion)
Secondary hyperparathyroidism (被刺激放多D PTH)
- disorder outside gland that leads to ↑↑ PTH
- Causes (**Hypocalcaemia):
1. Calcium deficiency
2. Vit D / Fat deficiency in diet
3. Lack of exposure of skin to sunlight
4. **Chronic kidney failure —> insufficient production of Calcitriol + low PO4 excretion
5. Calcitonin age-related decrease
—> 結果: ***Hypocalcaemia (or Normal Ca) —> ALL 4 glands becomes enlarged and overproduce PTH
Tertiary hyperparathyroidism (自動放多D PTH)
- **long-term secondary hyperparathyroidism
- parathyroid gland loses regulation
- **automatically secrete excess PTH (even after renal transplantation)
—> 結果: ***Hypercalcaemia
- Hypoparathyroidism
- parathyroid glands produce too little PTH
- Causes:
—> Accidental injury to parathyroid glands during head+neck surgery / radiation therapy to neck for thyroid cancer
—> Autoimmune destruction
—> Congenital
Hypercalcaemia caused by Hyperparathyroidism
- Painful bones
- weakening of bones (**osteoporosis, **bone pain, osteitis fibrosa) - Renal stones
- kidney problems (**polyuria, **renal stones) - Abdominal groans
- digestive problems (***constipation, indigestion, abdominal pain) - Psychic moans
- nervous system problems (fatigue, ***depression, memory loss, worsening concentration) - ***Muscle weakness (Negative bathmotropic effect: Ca inhibit Na channel), slow heart rate)
- CVS problems
- **Hypertension
- **Arrhythmia
Symptoms of Hypocalcaemia
mnemonic CATS:
- Convulsion
- Arrhythmia
- Tetany (***Chvostek’s sign —> hyperexcitability of face when tap on CN7)
- Spasm (***Trousseau’s sign —> use of BP cuff —> lack of blood flow to distal arm exacerbate hypoparathyroidism —> hyperexcitability)
Disorders related to Calcitriol
Vit D toxicity (Hypervitaminosis D)
- excess intake
- extrarenal elevation of 1α-hydroxylase activity e.g. granulomatous disease (Sarcoidosis)
—> Hypercalcaemia —> ↓ PTH
Vit D deficiency (Hypovitaminosis D)
- inadequate intake
- inadequate sunlight exposure
- mutation in CYP27B1 gene (↓ 1α-hydroxylase activity)
- problems in digestive tract (e.g. Crohn’s)
—> Hypocalcaemia —> ↑ PTH
***Summary of blood test
Hyperparathyroidism:
↑ PTH
—> ↑ Ca, ↓ Pi, ↑ Calcitriol
Hypoparathyroidism:
↓ PTH
—> ↓ Ca, ↑ Pi, ↓ Calcitriol
Vit D toxicity:
↑ 25(OH)D, ↑ Calcitriol (may be normal due to compensation from ↓ PTH)
—> ↑ Ca, ↑ Pi, ↓ PTH
Vit D deficiency:
↓ 25(OH)D, ↓ Calcitriol (may be normal due to compensation from ↑ PTH)
—> ↓ Ca, ↓ Pi, ↑ PTH
記住:
- ↑ PTH —> ↑ Calcitriol —> ↓ PTH
- ↑ PTH —> ↓ Pi
- ↑ Calcitriol —> ↑ Pi
- 兩個都↑ Ca